IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 90 filers reported holding IRADIMED CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,438,941 | +11.6% | 77,506 | +20.1% | 0.22% | +24.6% |
Q2 2023 | $3,081,406 | +8.4% | 64,546 | -10.7% | 0.18% | +8.0% |
Q1 2023 | $2,843,864 | +37.3% | 72,271 | -1.3% | 0.16% | +36.1% |
Q4 2022 | $2,071,903 | -9.6% | 73,238 | -3.9% | 0.12% | -10.5% |
Q3 2022 | $2,291,000 | -11.2% | 76,206 | +0.2% | 0.13% | +6.4% |
Q2 2022 | $2,581,000 | -29.0% | 76,044 | -6.3% | 0.12% | -13.8% |
Q1 2022 | $3,637,000 | -39.4% | 81,116 | -37.6% | 0.14% | -31.9% |
Q4 2021 | $6,004,000 | +48.5% | 129,930 | +7.9% | 0.21% | +43.0% |
Q3 2021 | $4,044,000 | -35.2% | 120,399 | -43.3% | 0.15% | -32.9% |
Q2 2021 | $6,244,000 | +5.2% | 212,325 | -7.8% | 0.22% | +15.0% |
Q1 2021 | $5,935,000 | +13.8% | 230,325 | +0.7% | 0.19% | +4.9% |
Q4 2020 | $5,217,000 | +10.2% | 228,794 | +3.3% | 0.18% | -3.7% |
Q3 2020 | $4,736,000 | +37.3% | 221,507 | +49.1% | 0.19% | +29.1% |
Q2 2020 | $3,449,000 | +134.5% | 148,609 | +115.6% | 0.15% | +80.5% |
Q1 2020 | $1,471,000 | +10.8% | 68,920 | +21.3% | 0.08% | +82.2% |
Q4 2019 | $1,328,000 | – | 56,811 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
RK Capital | 222,914 | $5,212,000 | 1.95% |
Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |